Therefore, exploring the impact of the PI3K/AKT pathway on GSK-3β, and its subsequent effects on the initiation and progression of HCC, offers a novel and promising avenue for future therapeutic interventions. This evidence concerns the gene AKT1 and hepatocellular carcinoma.